Plasma Market Dynamics & COVID19 Impact
Market trends in past 5+ years
•
●
•
·
Immunoglobulin sales have grown among the fastest for all plasma proteins
•
Strong volume and price growth - supply capped by plasma collections
Albumin has also grown, but more slowly
•
Volume growth has been steady, driven by China, but pricing has declined
Plasma derived factor VIII and IX demand has been declining due to recombinant and non-factor
competition
•
Pricing has been negatively affected by increased competition
Decline in usage in high income countries, but growing in emerging markets
Other Protein Trends:
•
•
Those with recombinant or non-plasma competition have declined (C1-INH)
Those without competition have grown (AAT)
•
Those prescribed for acute blood loss situations have grown (PCC and fibrinogen)
5
(MRBView entire presentation